MEDICINA MOLECULAR
![Foto de MEDICINA MOLECULAR](/img/grupo.png)
![Foto de Instituto Universitario de Oncologia del Principado de Asturias](/img/noimage_org.png)
Instituto Universitario de Oncologia del Principado de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (8)
2023
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
-
The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
Cancer research, Vol. 83, Núm. 2, pp. 239-250
2022
-
ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome
Journal of Clinical Medicine, Vol. 11, Núm. 1
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
-
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
The Lancet Regional Health - Europe, Vol. 18
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1